Announcing the new book by DermNet NZ

Download a FREE sample chapter

DOWNLOAD NOW

Metastatic Crohn disease pathology

Author: Harriet Cheng BHB, MBChB, Department of Dermatology, Waikato Hospital, Hamilton, New Zealand; A/Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2013.

Crohn disease patients may develop sterile granulomatous skin lesions at sites removed from the gastrointestinal tract This is known as metastatic Crohn disease (MCD). When it affects the skin, it is also called cutaneous Crohn disease. Clinically, MCD presents as a solitary or multiple nodules, plaques, ulcers, lichenoid lesions, or violaceous perifollicular papules.

Histology of metastatic Crohn disease

Metastatic Crohn disease is characterised by a dermal granulomatous infiltrate composed of epithelioid histiocytes (figures 1-5). There is an associated infiltrate which is mainly lymphocytic but may be rich in eosinophils. The granulomas may encroach on the epidermis (figure 1). Massive oedema may be seen (figure 2). Ulceration of the overlying epidermis is a common feature (figure 4).

Granulomatous vasculitis and necrosis may also be seen in metastatic Crohn disease.

Differential diagnosis of metastatic Crohn disease

Sarcoidosis: This may be a very difficult distinction without clinical correlation. Granulomata of Crohn disease are frequently less well-defined (figure 5) than in sarcoidosis. Ulceration is less common in sarcoidosis. Eosinophils are less dense in sarcoidosis.

Mycobacterial infection: Special stains and culture are required to exclude mycobacterial infection.

Granulomatous cheilitis (orofacial granulomatosis): This condition may be histologically identical. Clinical features help to differentiate.

 

Related information

Make a donation

Donate Today

Help us to update and maintain DermNet New Zealand

Submit your images

We are expanding our image library

Contact us

History of DermNet NZ

Watch Dr Amanda Oakley presenting 'The History Of DermNet NZ' at The International Society Of Teledermatology.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter